I'rom Group Co., Ltd. Logo

I'rom Group Co., Ltd.

2372.T

(3.2)
Stock Price

2.558,00 JPY

2.29% ROA

6.37% ROE

41.3x PER

Market Cap.

33.656.386.920,00 JPY

146.51% DER

1.44% Yield

4.61% NPM

I'rom Group Co., Ltd. Stock Analysis

I'rom Group Co., Ltd. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

I'rom Group Co., Ltd. Fundamental Stock Analysis
# Analysis Rating
1 ROE

ROE surpassing expectations (20.18%) highlights strong profitability and efficient use of shareholders' equity, making it an appealing investment prospect.

2 Revenue Growth

This company's revenue has experienced steady growth over the last five years, indicating a reliable and prosperous financial trajectory.

3 Net Profit Growth

This company's net profit has consistently grown over the last five years, indicating a strong financial performance and making it an attractive investment opportunity.

4 Assets Growth

This company's revenue has experienced steady growth over the last five years, indicating a reliable and prosperous financial trajectory.

5 ROA

The stock's ROA (8.74%) shows that it's doing a pretty good job at making money from its assets, making it a solid choice to invest and earn steady profits.

6 PBV

The stock's PBV ratio (2.12x) indicates a justifiable valuation, presenting a compelling choice for investors seeking reasonable returns.

7 Graham Number

The Graham number of this company suggests that its stock price may be undervalued, indicating a potentially attractive investment opportunity.

8 Dividend

The company's consistent dividend payments over the past three years indicate a strong commitment to delivering returns to investors.

9 Buffet Intrinsic Value

The company's stock shows potential as it is undervalued (20.475) according to Warren Buffett's formula, indicating that its intrinsic value exceeds the market price.

10 DER

The stock is burdened with a heavy load of debt (127%), making it financially unstable and potentially risky for investors.

11 Dividend Growth

Potential investors should be aware that the company's dividend growth has shown no upward trend in the past three years, indicating limited potential for increased returns.

I'rom Group Co., Ltd. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

I'rom Group Co., Ltd. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

I'rom Group Co., Ltd. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

I'rom Group Co., Ltd. Revenue
Year Revenue Growth
2007 13.726.000.000
2008 14.478.000.000 5.19%
2009 13.815.000.000 -4.8%
2010 13.990.000.000 1.25%
2011 11.018.000.000 -26.97%
2012 6.704.000.000 -64.35%
2013 4.011.000.000 -67.14%
2014 4.134.000.000 2.98%
2015 4.114.000.000 -0.49%
2016 4.890.000.000 15.87%
2017 8.621.000.000 43.28%
2018 10.578.000.000 18.5%
2019 10.593.000.000 0.14%
2020 12.906.000.000 17.92%
2021 15.693.000.000 17.76%
2022 18.351.000.000 14.48%
2023 16.076.000.000 -14.15%
2023 17.740.000.000 9.38%
2024 18.464.000.000 3.92%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

I'rom Group Co., Ltd. Research and Development Expenses
Year Research and Development Expenses Growth
2007 0
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 166.000.000 100%
2015 124.000.000 -33.87%
2016 128.000.000 3.13%
2017 107.000.000 -19.63%
2018 170.000.000 37.06%
2019 133.000.000 -27.82%
2020 135.000.000 1.48%
2021 582.000.000 76.8%
2022 859.000.000 32.25%
2023 244.000.000 -252.05%
2023 682.000.000 64.22%
2024 420.000.000 -62.38%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

I'rom Group Co., Ltd. General and Administrative Expenses
Year General and Administrative Expenses Growth
2007 422.000.000
2008 407.000.000 -3.69%
2009 419.000.000 2.86%
2010 360.000.000 -16.39%
2011 626.000.000 42.49%
2012 425.000.000 -47.29%
2013 458.000.000 7.21%
2014 459.000.000 0.22%
2015 459.000.000 0%
2016 455.000.000 -0.88%
2017 152.000.000 -199.34%
2018 186.000.000 18.28%
2019 171.000.000 -8.77%
2020 230.000.000 25.65%
2021 176.000.000 -30.68%
2022 178.000.000 1.12%
2023 240.000.000 25.83%
2023 498.000.000 51.81%
2024 472.000.000 -5.51%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

I'rom Group Co., Ltd. EBITDA
Year EBITDA Growth
2007 3.189.000.000
2008 3.108.000.000 -2.61%
2009 2.571.000.000 -20.89%
2010 2.442.000.000 -5.28%
2011 -360.000.000 778.33%
2012 1.208.000.000 129.8%
2013 135.000.000 -794.81%
2014 207.000.000 34.78%
2015 90.000.000 -130%
2016 1.175.000.000 92.34%
2017 1.386.000.000 15.22%
2018 1.448.000.000 4.28%
2019 1.438.000.000 -0.7%
2020 1.703.000.000 15.56%
2021 3.388.000.000 49.73%
2022 4.463.000.000 24.09%
2023 892.000.000 -400.34%
2023 2.271.000.000 60.72%
2024 1.612.000.000 -40.88%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

I'rom Group Co., Ltd. Gross Profit
Year Gross Profit Growth
2007 3.987.000.000
2008 4.313.000.000 7.56%
2009 3.889.000.000 -10.9%
2010 3.859.000.000 -0.78%
2011 2.629.000.000 -46.79%
2012 2.102.000.000 -25.07%
2013 1.070.000.000 -96.45%
2014 829.000.000 -29.07%
2015 1.121.000.000 26.05%
2016 1.802.000.000 37.79%
2017 3.511.000.000 48.68%
2018 4.055.000.000 13.42%
2019 4.261.000.000 4.83%
2020 4.429.000.000 3.79%
2021 7.240.000.000 38.83%
2022 9.066.000.000 20.14%
2023 6.308.000.000 -43.72%
2023 7.505.000.000 15.95%
2024 7.580.000.000 0.99%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

I'rom Group Co., Ltd. Net Profit
Year Net Profit Growth
2007 -1.090.000.000
2008 -10.884.000.000 89.99%
2009 -731.000.000 -1388.92%
2010 226.000.000 423.45%
2011 -364.000.000 162.09%
2012 1.751.000.000 120.79%
2013 -294.000.000 695.58%
2014 -606.000.000 51.49%
2015 -868.000.000 30.18%
2016 204.000.000 525.49%
2017 1.558.000.000 86.91%
2018 912.000.000 -70.83%
2019 1.236.000.000 26.21%
2020 1.373.000.000 9.98%
2021 1.961.000.000 29.98%
2022 2.542.000.000 22.86%
2023 804.000.000 -216.17%
2023 1.415.000.000 43.18%
2024 1.164.000.000 -21.56%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

I'rom Group Co., Ltd. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2007 -117
2008 -1.164 90.03%
2009 -78 -1391.03%
2010 24 425%
2011 -39 163.16%
2012 187 120.32%
2013 -31 723.33%
2014 -59 49.15%
2015 -82 27.16%
2016 19 550%
2017 135 86.67%
2018 78 -73.08%
2019 106 25.71%
2020 114 7.89%
2021 162 29.63%
2022 210 22.86%
2023 66 -218.18%
2023 117 43.1%
2024 96 -20.83%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

I'rom Group Co., Ltd. Free Cashflow
Year Free Cashflow Growth
2007 -2.450.000.000
2008 -909.000.000 -169.53%
2009 121.000.000 851.24%
2010 587.000.000 79.39%
2011 -354.000.000 265.82%
2012 -1.094.000.000 67.64%
2013 -192.000.000 -469.79%
2014 -796.000.000 75.88%
2015 -379.000.000 -110.03%
2016 -1.461.000.000 74.06%
2017 1.523.000.000 195.93%
2018 -1.363.000.000 211.74%
2019 -764.000.000 -78.4%
2020 -2.262.000.000 66.22%
2021 588.000.000 484.69%
2022 -606.000.000 197.03%
2023 0 0%
2023 -3.579.000.000 100%
2024 0 0%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

I'rom Group Co., Ltd. Operating Cashflow
Year Operating Cashflow Growth
2007 -1.339.000.000
2008 -780.000.000 -71.67%
2009 345.000.000 326.09%
2010 720.000.000 52.08%
2011 -101.000.000 812.87%
2012 -625.000.000 83.84%
2013 -45.000.000 -1288.89%
2014 -785.000.000 94.27%
2015 -271.000.000 -189.67%
2016 -826.000.000 67.19%
2017 1.612.000.000 151.24%
2018 504.000.000 -219.84%
2019 637.000.000 20.88%
2020 374.000.000 -70.32%
2021 2.630.000.000 85.78%
2022 3.561.000.000 26.14%
2023 0 0%
2023 446.000.000 100%
2024 0 0%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

I'rom Group Co., Ltd. Capital Expenditure
Year Capital Expenditure Growth
2007 1.111.000.000
2008 129.000.000 -761.24%
2009 224.000.000 42.41%
2010 133.000.000 -68.42%
2011 253.000.000 47.43%
2012 469.000.000 46.06%
2013 147.000.000 -219.05%
2014 11.000.000 -1236.36%
2015 108.000.000 89.81%
2016 635.000.000 82.99%
2017 89.000.000 -613.48%
2018 1.867.000.000 95.23%
2019 1.401.000.000 -33.26%
2020 2.636.000.000 46.85%
2021 2.042.000.000 -29.09%
2022 4.167.000.000 51%
2023 0 0%
2023 4.025.000.000 100%
2024 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

I'rom Group Co., Ltd. Equity
Year Equity Growth
2007 14.436.000.000
2008 3.451.000.000 -318.31%
2009 2.481.000.000 -39.1%
2010 2.674.000.000 7.22%
2011 2.273.000.000 -17.64%
2012 4.021.000.000 43.47%
2013 4.486.000.000 10.37%
2014 4.613.000.000 2.75%
2015 3.681.000.000 -25.32%
2016 4.473.000.000 17.71%
2017 5.746.000.000 22.15%
2018 6.063.000.000 5.23%
2019 7.165.000.000 15.38%
2020 8.710.000.000 17.74%
2021 10.161.000.000 14.28%
2022 12.153.000.000 16.39%
2023 12.772.000.000 4.85%
2023 12.960.000.000 1.45%
2024 13.113.000.000 1.17%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

I'rom Group Co., Ltd. Assets
Year Assets Growth
2007 26.763.000.000
2008 16.459.000.000 -62.6%
2009 14.005.000.000 -17.52%
2010 13.160.000.000 -6.42%
2011 5.996.000.000 -119.48%
2012 5.832.000.000 -2.81%
2013 6.029.000.000 3.27%
2014 6.839.000.000 11.84%
2015 5.969.000.000 -14.58%
2016 8.518.000.000 29.92%
2017 11.267.000.000 24.4%
2018 13.514.000.000 16.63%
2019 15.105.000.000 10.53%
2020 20.889.000.000 27.69%
2021 26.588.000.000 21.43%
2022 35.129.000.000 24.31%
2023 37.148.000.000 5.44%
2023 36.248.000.000 -2.48%
2024 36.579.000.000 0.9%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

I'rom Group Co., Ltd. Liabilities
Year Liabilities Growth
2007 12.327.000.000
2008 13.008.000.000 5.24%
2009 11.524.000.000 -12.88%
2010 10.486.000.000 -9.9%
2011 3.723.000.000 -181.65%
2012 1.811.000.000 -105.58%
2013 1.543.000.000 -17.37%
2014 2.226.000.000 30.68%
2015 2.288.000.000 2.71%
2016 4.045.000.000 43.44%
2017 5.522.000.000 26.75%
2018 7.451.000.000 25.89%
2019 7.940.000.000 6.16%
2020 12.179.000.000 34.81%
2021 16.427.000.000 25.86%
2022 22.976.000.000 28.5%
2023 24.372.000.000 5.73%
2023 23.288.000.000 -4.65%
2024 23.466.000.000 0.76%

I'rom Group Co., Ltd. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
1461.68
Net Income per Share
67.31
Price to Earning Ratio
41.3x
Price To Sales Ratio
1.9x
POCF Ratio
29.07
PFCF Ratio
29.06
Price to Book Ratio
2.57
EV to Sales
2.57
EV Over EBITDA
39.49
EV to Operating CashFlow
39.29
EV to FreeCashFlow
39.29
Earnings Yield
0.02
FreeCashFlow Yield
0.03
Market Cap
33,66 Bil.
Enterprise Value
45,50 Bil.
Graham Number
1280.78
Graham NetNet
-967.06

Income Statement Metrics

Net Income per Share
67.31
Income Quality
1.42
ROE
0.06
Return On Assets
0.02
Return On Capital Employed
0.02
Net Income per EBT
0.65
EBT Per Ebit
2.42
Ebit per Revenue
0.03
Effective Tax Rate
0.35

Margins

Sales, General, & Administrative to Revenue
0.02
Research & Developement to Revenue
0.03
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.4
Operating Profit Margin
0.03
Pretax Profit Margin
0.07
Net Profit Margin
0.05

Dividends

Dividend Yield
0.01
Dividend Yield %
1.44
Payout Ratio
0
Dividend Per Share
40

Operating Metrics

Operating Cashflow per Share
95.64
Free CashFlow per Share
95.64
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
0.01
Return on Tangible Assets
0.02
Days Sales Outstanding
70.91
Days Payables Outstanding
12.89
Days of Inventory on Hand
23.49
Receivables Turnover
5.15
Payables Turnover
28.32
Inventory Turnover
15.54
Capex per Share
0

Balance Sheet

Cash per Share
730,14
Book Value per Share
1.083,07
Tangible Book Value per Share
1006.42
Shareholders Equity per Share
1083.07
Interest Debt per Share
1602.09
Debt to Equity
1.47
Debt to Assets
0.53
Net Debt to EBITDA
10.28
Current Ratio
1.27
Tangible Asset Value
12,19 Bil.
Net Current Asset Value
-8,26 Bil.
Invested Capital
19200000000
Working Capital
3,19 Bil.
Intangibles to Total Assets
0.03
Average Receivables
4,08 Bil.
Average Payables
0,51 Bil.
Average Inventory
701000000
Debt to Market Cap
0.57

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

I'rom Group Co., Ltd. Dividends
Year Dividends Growth
2017 10
2018 20 50%
2019 30 33.33%
2020 40 25%
2021 40 0%
2022 25 -60%
2023 45 44.44%
2024 40 -12.5%

I'rom Group Co., Ltd. Profile

About I'rom Group Co., Ltd.

I'rom Group Co., Ltd. engages in the advanced medicinal treatment, site management organization, contract research organization, and medical support businesses in Japan. The company engages in the development of medical technologies, such as regenerative medicine and gene therapy for obstructive arteriosclerosis, retinitis pigmentosa, and human immunodeficiency virus infection and acquired immune deficiency syndrome, as well as Sendai virus vector and CytoTune-iPS, a kit for generating iPS cells. It also supports medical institutions in conducting clinical trials; provides clinical trial support services for new drug development and medical equipment for cancer, and rare and intractable diseases; and establishes and operates clinic malls. The company was formerly known as I'Rom Holdings Co., Ltd. and changed its name to I'rom Group Co., Ltd. in July 2015. I'rom Group Co., Ltd. was founded in 1997 and is headquartered in Tokyo, Japan.

CEO
Mr. Toyotaka Mori
Employee
1.029
Address
Iidabashi Grand Bloom
Tokyo, 102-0071

I'rom Group Co., Ltd. Executives & BODs

I'rom Group Co., Ltd. Executives & BODs
# Name Age
1 Mr. Toyotaka Mori
Chief Executive Officer, President & Director
70
2 Mr. Masaaki Matsushima
Executive Vice President & Director
70
3 Mr. Kiyoshi Watanabe
Executive Vice President
70
4 Hiroaki Inukai
Executive Vice President
70
5 Mr. Toshiya Hara
Executive Vice President & Director
70
6 Zhu Afeng
Executive Vice President
70

I'rom Group Co., Ltd. Competitors